Tell your state representative: Protect us from unfair prescription drug prices
Prescription drugs don't work if people can't afford them. A Prescription Drug Affordability Board will ensure fair, affordable prices for patients.
Joining other consumer organizations, PIRG submitted comments to the Federal Trade Commission (FTC) to recommend a broad investigation into the anticompetitive practices used by pharmacy benefit managers (PBMs). PBMS are the companies that manage the prescription drug portion of a health insurer’s benefits package. Our comments pointed out that “[i]n the past decade, PBM profits have more than doubled and increased to $28 billion annually.”
We urged the FTC to conduct a deep dive investigation into the PBM industry to “capture allegations of widespread fraudulent and deceptive practices.” Immediate attention by the FTC is necessary because the “PMB industry has avoided antitrust scrutiny for far too long.”
Photo Credit: Chris Potter on Flickr
Prescription drugs don't work if people can't afford them. A Prescription Drug Affordability Board will ensure fair, affordable prices for patients.
Send a message